Macro Finance
City Therapeutics Raises $200 Million in Upsized US IPO
Bloomberg Markets·October 16, 2026·1 min read
City Therapeutics Inc., an early-stage developer of RNA-based medicines, raised $200 million in an upsized US initial public offering. The company priced shares above the marketed range, reflecting strong demand from institutional investors. Proceeds will fund clinical development of its lead programs. The IPO marks the latest biotech listing in a recovering US market for new issues.
Read at Bloomberg MarketsDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.